Skip to main content

153SM-EDTMP for Pain Relief in Malignant and Benign Bone and Joint Diseases

  • Conference paper
Radioactive Isotopes in Clinical Medicine and Research XXIII

Part of the book series: Advances in Pharmacological Sciences ((APS))

  • 99 Accesses

Abstract

Management of bone pain in patients with disseminated skeletal metastases and also in patients with widespread benign inflammatory joint diseases unresponsive to all conventional treatment is a significant clinical problem.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Robinson RG., et al.: Radionuclide therapy of intractable bone pain: emphasis on strontium-89; Semin-Nucl-Med. 1992 Jan; 22(1): 28–32

    Article  PubMed  CAS  Google Scholar 

  2. Clarke SE.: Radionuclide therapy in oncology; Cancer-Treat-Rev. 1994 jan; 20(1): 51–71

    Article  PubMed  CAS  Google Scholar 

  3. Turner JH, Martindale AA, Sorby P, et al. Samarium-153 EDTMP therapy of disseminated skeletal metastasis. Eur J Nucl Med. 1989; 15:784–95.

    Article  PubMed  CAS  Google Scholar 

  4. Turner JH, Claringbold PG. A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonate. Eur J Cancer. 1991; 27:1084–6.

    Article  PubMed  CAS  Google Scholar 

  5. Ahonen A, Hiltunen J, Härkönen R, Jakobsen M, Jurvelin J, Joensuu H, Kumpulainen E, Kulmaml J, Nikula T. Pharmakokinetics of Samarium-153-EDTMP in Connection with a Treatment of Patients with Bone Metastases. Eur J Nucl Med 1992; 18:623

    Google Scholar 

  6. Blake GM et al., 89Sr therapy: Strontium kinetics in disseminated carcinoma of the prostate. Eur J Nucl Med 1986; 12:447–454

    PubMed  CAS  Google Scholar 

  7. Alberts AS, Brighton SW, Kempff P, et al. Samarium-153-EDTMP for palliation of ankylosing spondylitis, Paget’s disease and rheumatoid arthritis. J Nucl Med. 1995;36:1417–1420

    PubMed  CAS  Google Scholar 

  8. Marinho NVS, Nobre MRC, Coelho IJ, et al. Samarium-153-EDTMP for pain palliation in patients with rheumatoid arthritis. Eur J Nucl Med 1997; 24:963

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Basel AG

About this paper

Cite this paper

Kendler, D., Donnemiller, E., Riccabona, G., Mur, E. (1999). 153SM-EDTMP for Pain Relief in Malignant and Benign Bone and Joint Diseases. In: Bergmann, H., Köhn, H., Sinzinger, H. (eds) Radioactive Isotopes in Clinical Medicine and Research XXIII. Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8782-3_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8782-3_37

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9772-3

  • Online ISBN: 978-3-0348-8782-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics